SIM
MJN

Summitview Investment Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Summitview Investment Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-197,152
Closed -$14M – 9
2016
Q4 		$14M Sell
197,152
-82,848
-30% -$6.17M 12.73% 4
2016
Q3 		$22.1M Buy
+280,000
New +$23.9M 27.06% 2

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Summitview Investment Management's MJN Position: Q1 2017 in Review

Summitview Investment Management sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 197,152 shares — an estimated $14M sold.

Summitview Investment Management first reported a position in MJN in Q3 2016 and held it in 2 quarters. The position peaked at $22.1M in Q3 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Summitview Investment Management reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Summitview Investment Management sold 197,152 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $14M.
  • Summitview Investment Management first reported a position in Mead Johnson Nutrition Company in Q3 2016 and held it in 2 quarters.
  • Summitview Investment Management's Mead Johnson Nutrition Company position peaked at $22.1M in Q3 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Summitview Investment Management's 13F filing for Q1 2017, filed 11 May 2017.